Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1258-1267

  Terzi, E ^a   Golfieri, R ^a   Piscaglia, F ^a   Galassi, M ^a   Dazzi, A ^a   Leoni, S ^a   Giampalma, E ^a   Renzulli, M ^a   Bolondi, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Complete radiological response; Hepatocellular carcinoma; Repeated conventional transarterial chemoembolization; Tumor recurrence

Indexed keywords

ALBUMIN; BILIRUBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 84869231203     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.025     Document Type: Article

References (23)

1. J. Bruix, and M. Sherman Practice guidelines committee, american association for the study of liver disease. Management of hepatocellular carcinoma. An update Hepatology 53 3 2011 1020 1022
2. L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, and N. Davies Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
3. B. Sangro, D. D'Avola, M. Inarrairaegui, and J. Prieto Transarterial therapies for hepatocellular carcinoma Expert Opin Pharmacother 12 2011 1057 1073
4. T. Monna, T. Kanno, T. Marumo, S. Harihara, T. Kuroki, and S. Yamamoto A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma Gastroenterol Jpn 17 1982 542 549
5. T.J. Vogl, M. Trapp, H. Schroeder, M. Mack, A. Schuster, and J. Schmitt Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center Radiology 214 2000 349 357
6. P.C. Kwok, T.W. Lam, S.C. Chan, C.P. Chung, W.K. Wong, and M.K. Chan A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma J Hepatol 32 2000 955 964
7. O. Ernst, G. Sergent, D. Mizrahi, O. Delemazure, J.C. Paris, and C. L'Hermine Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1999 59 64
8. J.L. Raoul, B. Sangro, A. Forner, V. Mazzaferro, F. Piscaglia, and L. Bolondi Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization Cancer Treat Rev 37 2011 212 220
9. R. Salem, R.J. Lewandowski, M.F. Mulcahy, A. Riaz, R.K. Ryu, and S. Ibrahim Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 2010 52 64
10. B. Sangro, L. Carpanese, R. Cianni, R. Golfieri, D. Gasparini, and S. Ezziddin Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across barcelona clinic liver cancer stages: a European evaluation Hepatology 54 2011 868 878
11. A.L. Cheng, Y.K. Kang, Z. Chen, C.J. Tsao, S. Qin, and J.S. Kim Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 2009 25 34
12. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
13. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
14. F. Piscaglia, V. Camaggi, M. Ravaioli, G.L. Grazi, M. Zanello, and S. Leoni A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system Liver Transpl 13 2007 857 866
15. M. Cescon, G. Vetrone, G.L. Grazi, G. Ercolani, M. Ravaioli, and M. Del Gaudio Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years Ann Surg 249 2009 995 1002
16. R. Golfieri, A. Cappelli, A. Cucchetti, F. Piscaglia, M. Carpenzano, and E. Peri Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas Hepatology 53 2011 1580 1589
17. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
18. K. Takayasu, S. Arii, I. Ikai, M. Omata, K. Okita, and T. Ichida Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2006 461 469
19. C. Camma, F. Schepis, A. Orlando, M. Albanese, L. Shahied, and F. Trevisani Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
20. J. Lammer, K. Malagari, T. Vogl, F. Pilleul, A. Denys, and A. Watkinson Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
21. K. Malagari, K. Chatzimichael, E. Alexopoulou, A. Kelekis, B. Hall, and S. Dourakis Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 2008 269 280
22. M. Varela, M.I. Real, M. Burrel, A. Forner, M. Sala, and M. Brunet Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 2007 474 481
23. F. Piscaglia, and L. Bolondi The intermediate hepatocellular carcinoma stage: should treatment be expanded? Dig Liver Dis 42 Suppl. 3 2010 S258 S263